{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:34:12Z","timestamp":1767846852406,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases (NIAID)","doi-asserted-by":"crossref","award":["U19AI062629"],"award-info":[{"award-number":["U19AI062629"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000097","name":"NCRR","doi-asserted-by":"crossref","award":["P20RR15577"],"award-info":[{"award-number":["P20RR15577"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.03.011","type":"journal-article","created":{"date-parts":[[2011,4,4]],"date-time":"2011-04-04T01:35:05Z","timestamp":1301880905000},"page":"3670-3678","source":"Crossref","is-referenced-by-count":25,"title":["Anthrax vaccination induced anti-lethal factor IgG: Fine specificity and neutralizing capacity"],"prefix":"10.1016","volume":"29","author":[{"given":"Sherry R.","family":"Crowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Garman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata J.M.","family":"Engler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Darise","family":"Farris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy D.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Harley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.03.011_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10254-004-0028-2","article-title":"Anthrax toxins","volume":"152","author":"Mourez","year":"2004","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0010","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/IAI.68.4.1781-1786.2000","article-title":"Role of toxin functional domains in anthrax pathogenesis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mib.2004.12.005","article-title":"Interactions between anthrax toxin receptors and protective antigen","volume":"8","author":"Scobie","year":"2005","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/IAI.63.1.82-87.1995","article-title":"Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases","volume":"63","author":"Gordon","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0025","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1073\/pnas.0405405101","article-title":"Structure of heptameric protective antigen bound to an anthrax toxin receptor: A role for receptor in ph-dependent pore formation","volume":"101","author":"Lacy","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0002-9440(10)61218-7","article-title":"Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice","volume":"167","author":"Firoved","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0035","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1128\/IAI.70.9.4997-5007.2002","article-title":"Anthrax edema toxin requires influx of calcium for inducing cyclic amp toxicity in target cells","volume":"70","author":"Kumar","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0040","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm0803-996","article-title":"Anthrax delivers a lethal blow to host immunity","volume":"9","author":"Starnbach","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.20041557","article-title":"Anthrax toxins suppress t lymphocyte activation by disrupting antigen receptor signaling","volume":"201","author":"Paccani","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/n35101998","article-title":"Crystal structure of the anthrax lethal factor","volume":"414","author":"Pannifer","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-5793(02)03228-3","article-title":"Effect of bacillus anthracis lethal toxin on human peripheral blood mononuclear cells","volume":"527","author":"Popov","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0060","doi-asserted-by":"crossref","first-page":"52473","DOI":"10.1074\/jbc.M409105200","article-title":"Involvement of domain ii in toxicity of anthrax lethal factor","volume":"279","author":"Liang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1286-4579(00)00280-X","article-title":"Microbial metalloproteases and pathogenesis","volume":"2","author":"Miyoshi","year":"2000","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0070","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.58.6.1606-1613.1990","article-title":"Production and characterization of monoclonal antibodies against the lethal factor component of bacillus anthracis lethal toxin","volume":"58","author":"Little","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0075","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0080","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1081\/CLT-100102886","article-title":"Use of anthrax vaccine in the United States: Recommendations of the advisory committee on immunization practices","volume":"39","year":"2001","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0216204","article-title":"Development of an improved vaccine for anthrax","volume":"110","author":"Leppla","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0095","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0100","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0105","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00200-09","article-title":"Novel chimpanzee\/human monoclonal antibodies that neutralize anthrax lethal factor: evidence for possible synergy with anti-pa antibody","author":"Chen","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/IAI.00788-08","article-title":"Sequential b-cell epitopes of bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies","volume":"77","author":"Nguyen","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0120","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.00529-07","article-title":"In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity","volume":"75","author":"Staats","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/HAB-2003-12404","article-title":"Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model","volume":"12","author":"Zhao","year":"2003","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0130","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin g antibodies to anthrax toxin protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0135","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/653495","article-title":"Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge","volume":"202","author":"Crowe","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/art.21682","article-title":"An altered immune response to epstein-barr nuclear antigen 1 in pediatric systemic lupus erythematosus","volume":"54","author":"McClain","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0150","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.156.10.4018","article-title":"Human lupus anti-spliceosome a protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns","volume":"156","author":"James","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0155","first-page":"58","article-title":"Lupus humoral autoimmunity induced in a primate model by short peptide immunization","volume":"46","author":"Arbuckle","year":"1998","journal-title":"J Investig Med"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/504806","article-title":"Long-lasting t cell responses to biological warfare vaccines in human vaccinees","volume":"43","author":"Allen","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0165","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1073\/pnas.0306267101","article-title":"Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response","volume":"101","author":"McClain","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","article-title":"Characterization of the human immune response to the uk anthrax vaccine","volume":"42","author":"Baillie","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0175","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1134\/S1068162008050063","article-title":"Special features of immune response to the lethal toxin of bacillus anthracis","volume":"34","author":"Belova","year":"2008","journal-title":"Russ J Bioorg Chem+"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0180","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.vaccine.2007.05.018","article-title":"Immune response to two different dosing schedules of the anthrax vaccine precipitated (avp) vaccine","volume":"25","author":"Hepburn","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0185","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial","volume":"300","author":"Marano","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0190","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2005.09.058","article-title":"Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population","volume":"24","author":"Gardner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/338014","article-title":"Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine","volume":"185","author":"Gelder","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1517\/14622416.5.4.417","article-title":"Variation in vaccine response in normal populations","volume":"5","author":"Ovsyannikova","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0205","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between snps in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0210","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2007.04.036","article-title":"Variations in measles vaccine-specific humoral immunity by polymorphisms in slam and cd46 measles virus receptors","volume":"120","author":"Dhiman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(02)11083-X","article-title":"Differential genetic determination of immune responsiveness to hepatitis b surface antigen and to hepatitis a virus: a vaccination study in twins","volume":"360","author":"Hohler","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0220","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/S0264-410X(02)00267-0","article-title":"Il-1beta gene polymorphisms influence hepatitis b vaccination","volume":"20","author":"Yucesoy","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.011_bib0225","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1086\/521370","article-title":"Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine","volume":"196","author":"Tang","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100363X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100363X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:52:18Z","timestamp":1686012738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1100363X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":45,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X1100363X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}